Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

Completed

Conditions studied: Atopic Dermatitis

In brief

Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by recurrent viral skin infections. Recent studies have demonstrated that the skin of people with AD my have decreased antimicrobial peptide (AMP) expression. The purpose of this study is to compare smallpox virus replication and the number of AMPs and other antiviral molecules in people with AD, as compared to those seen in people with psoriasis or asthma, or healthy individuals.

Key facts

Study ID
NCT00407069
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
286
Starts
2005-06-01
Expected to finish
2010-02-01
Last updated by the study team
2016-10-18

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.